Loading
IB
Immunotech Biopharm Ltd. - B Stock: price and insider trades · Hong Kong
Immunotech Biopharm Ltd. - B: what insiders have been doing
This page follows insider dealings at Immunotech Biopharm Ltd. - B as filed with HKEX, a company from the Health Care sector. The last twelve months, up to 21 October 2026, brought 2 filings signed by 1 insider.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
With 2 filings in twelve months, the company is quieter than the median of 4 filings across the 1,315 companies we follow on the same exchange. Since 2020, the database holds no purchases and 13 sales by insiders of the company.
No insider has bought Immunotech Biopharm Ltd. - B shares on the open market in the past twelve months.
Elsewhere in the same sector, our signals recently picked up insider purchases at Xenon Pharmaceuticals Inc. and Vivos Inc. Source: insider filings from HKEX. Past trades are no guide to future returns.
Insider Decl.
24
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
13 ops. · all time
Who traded when
BuySaleJUNG Hyun Chul10 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$0.39
Analyst consensus
Income statement
EBITDA-HK$168.8M
Net income-HK$230.8M0.0% margin
Valuation
Beta0.09
Balance sheet & cash
Market capHK$237.7M
Total debtHK$440.3M
Free Cash Flow-HK$111.9M
Profitability & ownership
ROA-20.6%
% insiders79.7%
% institutions6.4%
Last declaration on 23 February 2026
Declarations24 total
43,000 sharesShareXHKGHKEX:DA20250922E00442
96,000 sharesShareXHKGHKEX:DA20250922E00443
4,000 sharesShareXHKGHKEX:DA20250922E00452
78,000 sharesShareXHKGHKEX:DA20250922E00441
100,000 sharesShareXHKGHKEX:DA20250307E00326
50,000 sharesShareXHKGHKEX:DA20250306E00349
50,000 sharesShareXHKGHKEX:DA20250306E00350
47,000 sharesShareXHKGHKEX:DA20250304E00199
211,000 sharesShareXHKGHKEX:DA20250304E00198
250,000 sharesShareXHKGHKEX:DA20250304E00197
90,128,571 sharesShareXHKGHKEX:DA20230411E00480
90,128,571 sharesShareXHKGHKEX:DA20221102E00314
22,410,000 sharesShareXHKGHKEX:DA20211231E00371
22,410,000 sharesShareXHKGHKEX:DA20211231E00370
134,948,571 sharesShareXHKGHKEX:DA20200806E00041
134,948,571 sharesShareXHKGHKEX:DA20200723E00053
24 of 24 declarations
About Immunotech Biopharm Ltd. - B
Immunotech Biopharm Ltd. - B is a company listed on the Hong Kong Stock Exchange, specializing in the development of biopharmaceutical products. It focuses on innovative solutions for the treatment of serious diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations